IL2 and pancreatic neoplasm: Tumor bulks (n = 3) from KPC06 mice treated with FOLFOX, L19-IL2, and the combination of both agents were characterized by 3’mRNA-seq to unravel the effects of L19-IL2 on pancreatic tumors (Fig. 5a).